BLC — Bastide le Confort Medical SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €128.69m
- €530.59m
- €508.03m
- 80
- 78
- 10
- 58
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5.09 | 12.6 | 14.3 | 14.3 | 16.8 |
Depreciation | |||||
Non-Cash Items | 0.814 | 1.01 | 4.25 | 1.81 | 2.77 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 17.8 | -13.6 | 4.97 | -18.7 | 27.4 |
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 61 | 47.3 | 74.4 | 56.9 | 106 |
Capital Expenditures | -34.4 | -39.8 | -46.5 | -53.3 | -53.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -17.2 | -11.1 | -26.9 | -51.2 | -22.6 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -51.6 | -50.9 | -73.4 | -104 | -76.2 |
Financing Cash Flow Items | -7.08 | -7.73 | -8.42 | -10.5 | -14.9 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -22.1 | 18.5 | 1.34 | 29.4 | -7.89 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -12.7 | 14.7 | 2.83 | -18.1 | 21.5 |